UNICA IRIS Institutional Research Information System

CASTELLI, MARIA PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 129.444
NA - Nord America 6.216
AS - Asia 2.182
SA - Sud America 332
AF - Africa 40
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 138.234
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 127.937
US - Stati Uniti d'America 6.135
SG - Singapore 942
CN - Cina 878
SE - Svezia 398
UA - Ucraina 374
BR - Brasile 272
DE - Germania 197
GB - Regno Unito 168
FI - Finlandia 124
VN - Vietnam 103
CA - Canada 62
FR - Francia 60
KR - Corea 57
IN - India 43
HK - Hong Kong 39
NL - Olanda 29
PL - Polonia 28
AR - Argentina 23
RU - Federazione Russa 23
AT - Austria 19
BE - Belgio 19
JP - Giappone 19
BD - Bangladesh 14
CZ - Repubblica Ceca 14
ES - Italia 12
IQ - Iraq 11
MA - Marocco 11
AU - Australia 10
MX - Messico 10
TR - Turchia 10
UZ - Uzbekistan 10
ZA - Sudafrica 10
ID - Indonesia 8
CL - Cile 7
EC - Ecuador 7
IE - Irlanda 7
IL - Israele 7
VE - Venezuela 7
EU - Europa 6
IR - Iran 5
PY - Paraguay 5
CO - Colombia 4
DK - Danimarca 4
EE - Estonia 4
EG - Egitto 4
KE - Kenya 4
NO - Norvegia 4
PE - Perù 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CY - Cipro 1
HR - Croazia 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SR - Suriname 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 138.234
Salva come PNG Salva come JPEG
Città #
Cagliari 124.950
Uta 2.670
Fairfield 612
Dallas 547
Ashburn 509
Woodbridge 481
Chandler 415
Houston 409
Singapore 406
Boardman 272
Ann Arbor 269
Seattle 235
Wilmington 232
Nyköping 231
Jacksonville 203
Cambridge 202
Beijing 173
Dearborn 136
Los Angeles 94
Santa Clara 91
Shanghai 84
Hefei 82
New York 79
The Dalles 67
Boston 62
Munich 62
Nanjing 61
Helsinki 59
Seoul 57
Buffalo 40
Hong Kong 38
San Diego 34
Nanchang 31
Dong Ket 29
Ho Chi Minh City 28
Hebei 25
Brooklyn 23
Hanoi 23
Shenyang 23
Washington 23
Milan 22
Mountain View 22
Redwood City 22
Tianjin 22
London 20
Verona 18
Changsha 17
Chicago 17
Guangzhou 17
Sassari 17
São Paulo 17
Toronto 17
Warsaw 17
Brussels 16
Jiaxing 16
Jinan 15
Norwalk 15
Phoenix 15
Redondo Beach 15
Rome 15
Frankfurt am Main 14
Atlanta 13
Montreal 13
Stockholm 13
Vienna 13
Falls Church 12
Tokyo 12
Denver 11
Wuhan 11
Council Bluffs 10
Hangzhou 10
Nuremberg 10
Auburn Hills 9
Casablanca 9
Orem 9
San Francisco 9
Orange 8
Tashkent 8
Victoria 8
Brno 7
Buenos Aires 7
Chennai 7
Johannesburg 7
Pittsburgh 7
Pune 7
Rio de Janeiro 7
Brasília 6
Columbus 6
Detroit 6
Dublin 6
Düsseldorf 6
Ningbo 6
Ottawa 6
Prague 6
Quartu Sant'elena 6
Tampa 6
Villafranca di Verona 6
Zhengzhou 6
Amsterdam 5
Cedar Knolls 5
Totale 134.752
Salva come PNG Salva come JPEG
Nome #
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons 5.745
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.575
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.127
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 4.105
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.856
Regional distribution of 5α-reductase type 2 in the adult rat brain: An immunohistochemical analysis 3.496
Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice 3.334
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.201
The agression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake. 3.135
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.052
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.940
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penilemerection: immunohistochemistry,autoradiography and behavvioral studies 2.747
Inhibition of steroid 5-alpha reductase reduces marble-burying responses in mice 2.665
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 2.609
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.578
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.559
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.559
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.528
Suppressing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on chocolate self-administration and reinstatement of chocolate seeking in rats 2.483
In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator 2.420
The new compound GET73, N-[(4-trifluoromethyl)benzyl]4-methoxybutyramide, regulates hippocampal aminoacidergic transmission possibly via an allosteric modulation of mGlu5 receptor. Behavioural evidence of its "anti-alcohol" and anxiolytic properties. 2.363
Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotoninergic toxicity 2.360
The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: Involvement of paraventricular glutamic acid and nitric oxide 2.303
In vitro functional characterization of GET73 as possible negative allosteric modulator of metabotropic glutamate receptor 5 2.215
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.120
Characterization of COR627 and COR628, Two Novel Positive Allosteric Modulators of the GABAB Receptor. 2.055
Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB(1) cannabinoid receptors 2.044
NMDA receptors mediate the role of monoamine oxidase A in pathological aggression 2.026
null 2.010
Distribution and localization of the GABAB receptor 1.905
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.896
Cannabis and the Use of Amphetamine-Like Substances 1.894
null 1.888
Persistent increase in CB1 receptor and amnestic effect of cannabinoid by methamphetamine 1.866
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe 1.844
(-) S amisulpride binds with high affinity to cloned dopamine D3 and D2 receptors 1.779
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.778
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioural studies 1.775
Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73. 1.678
Localization of steroid 5α-reductase type 2 isozyme in the adult rat brain 1.669
Differential G-protein coupling to GABAB receptor in limbic areas of alcohol-preferring and -nonpreferring rats 1.649
A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor 1.500
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.440
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 1.355
Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors 1.345
Sex and gender differences in the effects of novel psychoactive substances 1.324
Changes induced by acute toxic dose (ATD) of methanphetamine (METH) on cannabinoid CB1 receptors: An immunocytochemistry study 1.223
Methamphetamine-induced damages of serotoninergic and dopaminergic terminals are not paralleled by overt mnemonic and pre-attentional alterations 1.118
COR758, a negative allosteric modulator of GABAB receptors 1.093
The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 1.084
Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug of abuse 1.007
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 989
Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances 989
Predisposition to alcohol drinking and alcohol consumption alter expression of calcitonin gene-related peptide, neuropeptide Y, and microglia in bed nucleus of stria terminalis in a subnucleus-specific manner 960
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 916
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists 837
Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911 803
Distribution of GABA B receptor mRNAs in the rat brain and peripheral organs 732
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 710
Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid 674
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 651
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists 626
Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations 616
Continuous subcutaneous insulin infusion (CSII) in pregnant diabetic patients 614
Thyroid transcription factor 1 activates the promoter of the tyrothropin receptor gene 602
Central effects of 1,4-butanediol are mediated by GABAB receptors via its conversion into gamma-hydroxybutyric acid 596
Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain 594
3‐[3‐(Phenalkylamino)cyclohexyl]phenols: Synthesis, biological activity, and in silico investigation of a naltrexone‐derived novel class of MOR‐antagonists 575
Immune and glial cell alterations in the rat brain after repeated exposure to the synthetic cannabinoid JWH-018 564
CATHEPSIN-G INDUCED RELEASE OF PAI-1 IN THE CULTURE-MEDIUM OF ENDOTHELIAL-CELLS - A NEW THROMBOGENIC ROLE FOR POLYMORPHONUCLEAR LEUKOCYTES 556
Molecular pharmacology of the Beta-adrenergic receptor on THP-1 cells 540
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor 533
Recombinant cytokines IL-2, IL-1, IFN-G, G-CSF and GM-CSF augment CFU-C activity in normal, cyclophosphamide-treated or irradiated mice as well as reduce the lethality of these myelotoxic agents 532
Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors 515
Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients 511
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 506
Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)-thiophene-3-carboxamides and analogues thereof 486
Effects of Antiestrogen and Progestin on Immune Functions in Breast Cancer Patients 483
Regioselective synthesis of new EWG-Bearing 3-benzoyl-2-phenylbenzofurans by one-pot intramolecular acylation/thermal cyclization of phosphoranes and their CB1 antagonist activity 448
null 448
Correlations between Gustatory, Olfactory, Cognitive Function, and Age in Healthy Women 366
null 281
Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity 265
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 202
Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. 182
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 150
Correction to: Adolescent self‑administration of the synthetic cannabinoid receptor agonist JWH‑018 induces neurobiological and behavioral alterations in adult male mice 132
The novel synthesized naltrexone-related MOR antagonist AT-99 counteracts dopamine releasing and behavioral depressant morphine-induced effects 40
Totale 138.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.944 0 0 0 0 0 3.149 2.089 1.683 593 1.188 1.360 882
2021/20228.243 880 634 608 439 637 731 503 406 488 724 1.197 996
2022/202311.794 1.081 1.320 1.207 976 906 1.542 559 834 821 866 1.130 552
2023/202411.633 608 476 452 640 1.130 1.776 1.899 760 667 786 1.221 1.218
2024/202517.382 3.469 4.091 2.513 2.375 1.338 1.280 1.225 146 280 185 239 241
2025/20263.070 488 336 919 459 490 378 0 0 0 0 0 0
Totale 138.544